Announcing Katrin Braasch as General Manager of Carlo Genetics

Jun 05, 2023

Carlo Genetics is pleased to announce that effective June 1, 2023, Katrin Braasch has taken over the role of General Manager, succeeding Kyla Ripley. Since 2020 Katrin has worked with all departments at Carlo Genetics and proved her dedication to upholding Carlo’s ongoing commitment to quality, service, and
technology.

“I am excited to transition into the role of GM at Carlo Genetics and will continue to work together with our excellent team to serve our customers with the same transparency that Carlo is known for,” said Katrin.Katrin Braasch holds a Ph.D. in Microbiology from the University of Manitoba and B.Sc. (Hons) in
Biochemistry from the University of Winnipeg. The use of image-based cell analysis during her academic work has direct crossover benefits to understanding and working with the CASA and cell count programming in place at Carlo Genetics.

“I am looking forward to the current and future advancements in the industry and how we are continually striving to improve in all aspects of the company as we continue providing a superior quality product to more farms,” said Katrin.

Originally from a small town outside Berlin, Germany, Katrin first visited Canada as an exchange student. She has lived full time in Manitoba since 2005 and, in addition to working with Carlo Genetics, Katrin runs a small, family cow-calf operation with her husband in Ste. Genevieve. “I have had the distinct pleasure of working with Katrin in her capacity as Assistant General Manager

since 2020, and I can personally attest to her dedication to upholding the quality, service and technology for which Carlo Genetics has become known. Carlo remains in good hands with Katrin now as General Manager,” said Kyla Ripley, Manager, Global Male Reproduction Services, AIM Worldwide.

Source : Carlogenetics

Video: New Solution Powers Efficient Pork Growth

Alltech has introduced Olerix, an innovative phytogenic blend created to promote growth and feed efficiency in pigs. Through a proprietary coating process, the bioactive blend of phytogenic compounds used in Olerix is designed to outlast the manufacturing process, ensuring consistent outcomes from feed to finish. The result is a high-impact efficiency solution that provides consistent support for gut health, feed efficiency, immune function and growth performance. Olerix is backed by validated trials conducted under modern pork production conditions.

“As the industry searches for technology to drive profitability forward in a more sustainable manner, we’re thrilled to join that effort with our Olerix technology,” said Mark Hulsebus, general manager for U.S. pork at Alltech. “Our work in this phytogenic space is yielding very encouraging results, and we’re excited to make this new opportunity available to pork producers focused on optimizing feed efficiency and growth rates.”

“Olerix represents the next generation of phytogenic technology — combining feed efficiency, livability and immune support into a practical commercial solution producers can implement today,” said Andy Rash, U.S. monogastric director at Alltech.